多发性硬化的癌症发病率与死亡率:一项匹配队列研究
该研究基于加拿大曼尼托巴省和安大略省人群数据,比较多发性硬化(MS)患者与匹配对照的癌症发病率和癌症特异性死亡率。纳入53,983例MS和269,915例对照,发现乳腺癌和结直肠癌风险无差异,但MS队列膀胱癌发病率和死亡率更高。
要点
- MS患者乳腺癌和结直肠癌发病风险与对照无显著差异
- MS队列膀胱癌发病率和死亡率均高于匹配对照
- 部分癌症发病率差异可能反映 ascertainment 差异而非真实差异
核心结论
- MS患者乳腺癌和结直肠癌发病率与对照无差异,但膀胱癌发病率升高。
研究设计与样本
- 回顾性匹配队列研究,使用加拿大曼尼托巴省和安大略省行政数据,纳入53,983例MS和269,915例对照。
主要发现
- 乳腺癌风险汇总HR 0.92(95%CI 0.78-1.09),结直肠癌风险汇总HR 0.83(95%CI 0.64-1.07)。
- 乳腺癌和结直肠癌死亡率在队列间无差异。
- MS队列膀胱癌发病率和死亡率较高。
- 前列腺癌、子宫癌和中枢神经系统癌症发病率在队列间有差异,但死亡率无差异。
临床怎么用
- MS患者乳腺癌和结直肠癌筛查可参照一般人群指南。
- 对MS患者膀胱癌相关症状保持警觉,考虑适当监测。
局限性
- 基于行政数据的回顾性研究,可能存在 ascertainment 偏倚。
- 部分癌症发病率差异可能反映 ascertainment 差异而非真实差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether cancer risk differs in people with and without multiple sclerosis (MS), we compared incidence rates and cancer-specific mortality rates in MS and matched cohorts using population-based data sources. METHODS: We conducted a retrospective matched cohort study using population-based administrative data from Manitoba and Ontario, Canada. We applied a validated case definition to identify MS cases, then selected 5 controls without MS matched on birth year, sex, and region. We linked these cohorts to cancer registries, and estimated incidence of breast, colorectal, and 13 other cancers. For breast and colorectal cancers, we constructed Cox models adjusting for age at the index date, area-level socioeconomic status, region, birth cohort year, and comorbidity. We pooled findings across provinces using meta-analysis. RESULTS: We included 53,983 MS cases and 269,915 controls. Multivariable analyses showed no difference in breast cancer risk (pooled hazard ratio [HR] 0.92 [95% confidence interval (CI) 0.78-1.09]) or colorectal cancer risk (pooled HR 0.83 [95% CI 0.64-1.07]) between the cohorts. Mortality rates for breast and colorectal did not differ between cohorts. Bladder cancer incidence and mortality rates were higher among the MS cohort. Although the incidence of prostate, uterine, and CNS cancers differed between the MS and matched cohorts, mortality rates did not. CONCLUSION: The incidence of breast and colorectal cancers does not differ between persons with and without MS; however, the incidence of bladder cancer is increased. Reported differences in the incidence of some cancers in the MS population may reflect ascertainment differences rather than true differences.
引用
- Marrie RA, Maxwell C, Mahar A, et al. Cancer Incidence and Mortality Rates in Multiple Sclerosis: A Matched Cohort Study. Neurology. 2020. PMID: 33239364. doi:10.1212/WNL.0000000000011219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。